<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mei Y</submitter><funding>Robert H. Lurie Comprehensive Cancer Center</funding><funding>Congressionally Directed Medical Research Programs</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>National Heart and Lung Institute</funding><funding>Leukemia and Lymphoma Society</funding><pagination>e152673</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9435651</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>132(17)</volume><pubmed_abstract>Myelodysplastic syndromes (MDS) are age-related myeloid neoplasms with increased risk of progression to acute myeloid leukemia (AML). The mechanisms of transformation of MDS to AML are poorly understood, especially in relation to the aging microenvironment. We previously established an mDia1/miR-146a double knockout (DKO) mouse model phenocopying MDS. These mice develop age-related pancytopenia with oversecretion of proinflammatory cytokines. Here, we found that most of the DKO mice underwent leukemic transformation at 12-14 months of age. These mice showed myeloblast replacement of fibrotic bone marrow and widespread leukemic infiltration. Strikingly, depletion of IL-6 in these mice largely rescued the leukemic transformation and markedly extended survival. Single-cell RNA sequencing anal</pubmed_abstract><journal>The Journal of clinical investigation</journal><pubmed_title>Bone marrow-confined IL-6 signaling mediates the progression of myelodysplastic syndromes to acute myeloid leukemia.</pubmed_title><pmcid>PMC9435651</pmcid><funding_grant_id>R01 HL150729</funding_grant_id><funding_grant_id>R01-DK124220</funding_grant_id><funding_grant_id>Translational Bridge Grant</funding_grant_id><funding_grant_id>R01 HL148012</funding_grant_id><funding_grant_id>R01-HL150729</funding_grant_id><funding_grant_id>R01-HL148012</funding_grant_id><funding_grant_id>CA140119</funding_grant_id><funding_grant_id>Scholar Award</funding_grant_id><funding_grant_id>R01 DK124220</funding_grant_id><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Xia Z</pubmed_authors><pubmed_authors>Zhang D</pubmed_authors><pubmed_authors>Xie X</pubmed_authors><pubmed_authors>Lu X</pubmed_authors><pubmed_authors>Mei Y</pubmed_authors><pubmed_authors>Li E</pubmed_authors><pubmed_authors>Han X</pubmed_authors><pubmed_authors>Dong L</pubmed_authors><pubmed_authors>Zou C</pubmed_authors><pubmed_authors>Altman JK</pubmed_authors><pubmed_authors>Sukhanova M</pubmed_authors><pubmed_authors>Ji P</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Ma A</pubmed_authors><pubmed_authors>Verma A</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Ren K</pubmed_authors><pubmed_authors>Bao H</pubmed_authors><pubmed_authors>Tariq H</pubmed_authors><pubmed_authors>Abaza Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bone marrow-confined IL-6 signaling mediates the progression of myelodysplastic syndromes to acute myeloid leukemia.</name><description>Myelodysplastic syndromes (MDS) are age-related myeloid neoplasms with increased risk of progression to acute myeloid leukemia (AML). The mechanisms of transformation of MDS to AML are poorly understood, especially in relation to the aging microenvironment. We previously established an mDia1/miR-146a double knockout (DKO) mouse model phenocopying MDS. These mice develop age-related pancytopenia with oversecretion of proinflammatory cytokines. Here, we found that most of the DKO mice underwent leukemic transformation at 12-14 months of age. These mice showed myeloblast replacement of fibrotic bone marrow and widespread leukemic infiltration. Strikingly, depletion of IL-6 in these mice largely rescued the leukemic transformation and markedly extended survival. Single-cell RNA sequencing anal</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-28T03:28:00.978Z</modification><creation>2025-02-19T00:44:01.081Z</creation></dates><accession>S-EPMC9435651</accession><cross_references><pubmed>35900794</pubmed><doi>10.1172/JCI152673</doi></cross_references></HashMap>